What is Retatrutide?
Retatrutide is a next-generation investigational peptide designed to tackle obesity, metabolic dysfunction, and insulin resistance. It functions as a triple agonist (GLP-1, GIP, and glucagon receptors), making it one of the most advanced compounds for fat loss, appetite regulation, and glucose control currently in research.
Early studies suggest that Retatrutide may outperform both Semaglutide and Tirzepatide in reducing body fat and improving metabolic health — with greater impact on energy expenditure and fat oxidation.
Key Benefits:
Who Should Use Retatrutide?
Retatrutide is ideal for advanced users exploring high-level fat loss and metabolic reset protocols, especially those who have used or plateaued on Semaglutide or Tirzepatide. It’s also relevant for those addressing insulin resistance or high body fat percentages.
Format: 10mg lyophilized peptide vial
Suggested Use: Research protocols often involve microdosing 0.25–1mg weekly, titrated over time (similar to GLP-1 dosing frameworks)
Storage: Store in refrigerator once reconstituted
Note: This product is intended for research purposes only
Retatrutide is a next-generation investigational peptide designed to tackle obesity, metabolic dysfunction, and insulin resistance. It functions as a triple agonist (GLP-1, GIP, and glucagon receptors), making it one of the most advanced compounds for fat loss, appetite regulation, and glucose control currently in research.
Early studies suggest that Retatrutide may outperform both Semaglutide and Tirzepatide in reducing body fat and improving metabolic health — with greater impact on energy expenditure and fat oxidation.
Key Benefits:
- ✅ Rapid and sustained fat loss
- ✅ Strong appetite suppression and reduced cravings
- ✅ Improves insulin sensitivity and blood sugar control
- ✅ Enhances metabolic rate and energy balance
- ✅ May support cardiovascular and liver health
- ✅ Powerful tool for obesity and type-2 diabetes research
Who Should Use Retatrutide?
Retatrutide is ideal for advanced users exploring high-level fat loss and metabolic reset protocols, especially those who have used or plateaued on Semaglutide or Tirzepatide. It’s also relevant for those addressing insulin resistance or high body fat percentages.
Format: 10mg lyophilized peptide vial
Suggested Use: Research protocols often involve microdosing 0.25–1mg weekly, titrated over time (similar to GLP-1 dosing frameworks)
Storage: Store in refrigerator once reconstituted
Note: This product is intended for research purposes only